Pacific Biosciences of California Inc. (PACB)
NASDAQ: PACBIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.70 -0.74%
PACB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $845.46M
- EPS (TTM)
- -$0.43
- Dividend yield
- None
- 52-week range
- 1.07 – 3.44
- Day range
- 2.50 – 2.74
- Volume / Avg
- 20.29M / 9.85M
- Beta
- —
- Shares outstanding
- 310.83M
- Next earnings
- Nov 4, 2026
52-week range
PACB stock today
Shares of Pacific Biosciences of California (PACB) finished higher on Oct 7 at $2.72, a gain of 0.74% or $0.02 per share, versus the S&P 500's 0.22% decline. Volume was 2.1x the average at 20.29M shares, a sign of unusually heavy trading. At this level, PACB sits in the middle of its 52-week range of $1.07 to $3.44: 20.9% below the high, set on Oct 6, 2026 and 154.2% above the low.
PACB is up 45.5% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 94.3%. Pacific Biosciences of California has posted a net loss over the last twelve months (EPS of -$0.43), so its P/E ratio is not meaningful. Pacific Biosciences of California's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Pacific Biosciences of California
Company profile- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- IPO year
- 2010
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.13
PACB news
All PACB newsPacific Biosciences of California peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CTKBCytek Biosciences Inc. | 5.34 | -0.74% | $694.11M | vs PACB |
| EYPTEyePoint Inc. | 3.32 | +4.73% | $278.35M | vs PACB |
| LABStandard BioTools Inc. | 0.6787 | -6.00% | $266.44M | vs PACB |
| NAUTNautilus Biotechnology Inc. | 1.96 | +10.73% | $249.42M | vs PACB |
| QTRXQuanterix Corporation | 3.33 | -3.34% | $157.25M | vs PACB |
| SEERSeer Inc. Class A | 2.21 | +0.91% | $122.37M | vs PACB |
| CIRCCircle8 Group Inc. | 0.46 | -7.26% | $52.63M | vs PACB |
| RPIDRapid Micro Biosystems Inc. Class A | 0.8977 | -4.76% | $45.03M | vs PACB |
Indexes, lists and sector
Pacific Biosciences of California stock FAQ
What is Pacific Biosciences of California's stock price today?
PACB last traded at $2.72 as of Oct 7, 4:00 PM EDT, up 0.74% on the day. Prices are delayed at least 15 minutes.
When is Pacific Biosciences of California's next earnings date?
Pacific Biosciences of California is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.13.
What is the PACB 52-week high?
The 52-week high for PACB is $3.44 and the 52-week low is $1.07. The stock is currently 20.9% below its high.